Iradimed IRMD
NASDAQ IRMD
$83.41 -0.99 (-1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT

Iradimed (IRMD) Notes Payables (2013)

Iradimed's (IRMD) quarterly Notes Payables came in at $6333.0 in Q4 2013.

Analysis

Iradimed (IRMD) Notes Payables (2013) Analysis & Trends

Iradimed (IRMD) has reported Notes Payables for 1 consecutive years, with $6333.0 the latest figure, recorded in Q4 2013.

  • On a quarterly basis, Notes Payables changed N/A year-over-year to $6333.0 in Q4 2013; TTM through Dec 2013 was $6333.0, a N/A change from a year earlier, with the FY2013 full-year figure at $6333.0, changed N/A from the prior year.
  • Notes Payables was $6333.0 for Q4 2013 at Iradimed.
  • Over five years, Notes Payables peaked at $6333.0 in Q4 2013 and troughed at $6333.0 in Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Iradimed 1.07 Bn 1.01 Bn 15.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 6,333.00